speb/financial-data huggingface dataset:
CTRM income_statement (annual, 2024-12-31) — Operating Revenue: 66243379.00
CTRM income_statement (quarterly, 2024-12-31) — Operating Revenue: 16163566.00
CTRM balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 9662354.00
CTRM balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 9662354.00
CTRM balance_sheet (annual, 2024-12-31) — Other Current Assets: 3773218.00
CTRM balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 3773218.00
CTRM balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 11023779.00
CTRM balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 11023779.00
CTRM balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 19045913.00
CTRM balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 19045913.00
CTRM balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -1509187.00
CTRM balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: -1509187.00
CTRM income_statement (annual, 2024-12-31) — Other Gand A: 6030425.00
CTRM income_statement (quarterly, 2024-12-31) — Other Gand A: 1404853.00
CTRM income_statement (annual, 2024-12-31) — Other Income Expense: 6131058.00
CTRM income_statement (quarterly, 2024-12-31) — Other Income Expense: -33433532.00
CTRM balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 19323603.00
CTRM balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 19323603.00
CTRM cash_flow (annual, 2024-12-31) — Other Non Cash Items: -1237638.00
CTRM cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: -376474.00
CTRM balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 323879.00
CTRM balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 323879.00
CTRM income_statement (annual, 2024-12-31) — Other Operating Expenses: 4808602.00
CTRM income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 1270332.00
CTRM balance_sheet (annual, 2024-12-31) — Other Properties: 7770979.00
CTRM balance_sheet (quarterly, 2024-12-31) — Other Properties: 7770979.00
CTRM balance_sheet (annual, 2024-12-31) — Other Receivables: 52084.00
CTRM balance_sheet (quarterly, 2024-12-31) — Other Receivables: 52084.00
CTRM balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 69119010.00
CTRM balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 69119010.00
CTRM income_statement (annual, 2024-12-31) — Other Special Charges: -1418096.00
CTRM income_statement (quarterly, 2024-12-31) — Other Special Charges: -6740.00
CTRM income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: -22437675.00
CTRM balance_sheet (annual, 2024-12-31) — Payables: 9658959.00
CTRM balance_sheet (quarterly, 2024-12-31) — Payables: 9658959.00
CTRM balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 32704474.00
CTRM balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 32704474.00
CTRM balance_sheet (annual, 2024-12-31) — Preferred Stock: 77708270.00
CTRM balance_sheet (quarterly, 2024-12-31) — Preferred Stock: 77708270.00
CTRM cash_flow (annual, 2024-12-31) — Preferred Stock Dividend Paid: -2500000.00
CTRM cash_flow (quarterly, 2024-12-31) — Preferred Stock Dividend Paid: -625000.00
CTRM income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 3252277.00
CTRM income_statement (quarterly, 2024-12-31) — Preferred Stock Dividends: 970963.00
CTRM balance_sheet (annual, 2024-12-31) — Preferred Stock Equity: 77708270.00
CTRM balance_sheet (quarterly, 2024-12-31) — Preferred Stock Equity: 77708270.00
CTRM cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 50000000.00
CTRM cash_flow (quarterly, 2024-12-31) — Preferred Stock Issuance: 50000000.00
CTRM cash_flow (annual, 2024-12-31) — Preferred Stock Payments: 0.00
CTRM income_statement (annual, 2024-12-31) — Pretax Income: 15438922.00
CTRM income_statement (quarterly, 2024-12-31) — Pretax Income: -32682577.00
CTRM cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: -1058481.00
CTRM cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
CTRM income_statement (annual, 2024-12-31) — Provision For Doubtful Accounts: 4823.00
CTRM cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 4823.00
CTRM cash_flow (annual, 2024-12-31) — Purchase Of Business: -163875084.00
CTRM cash_flow (annual, 2024-12-31) — Purchase Of Investment: -59903362.00
CTRM cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: -41787141.00
CTRM cash_flow (annual, 2024-12-31) — Purchase Of PPE: -72171465.00
CTRM cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -41914521.00
CTRM balance_sheet (annual, 2024-12-31) — Receivables: 20978328.00
CTRM balance_sheet (quarterly, 2024-12-31) — Receivables: 20978328.00
CTRM income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 46592111.00
CTRM income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 12674655.00
CTRM income_statement (annual, 2024-12-31) — Reconciled Depreciation: 15037006.00
CTRM income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 3988177.00
CTRM income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 0.00
CTRM cash_flow (annual, 2024-12-31) — Repayment Of Debt: -86866269.00
CTRM cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -1880965.00
CTRM cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
CTRM balance_sheet (annual, 2024-12-31) — Restricted Cash: 0.00
CTRM balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 0.00
CTRM income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 7017535.00
CTRM balance_sheet (annual, 2024-12-31) — Retained Earnings: 228527153.00
CTRM balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 228527153.00
CTRM income_statement (annual, 2024-12-31) — Salaries And Wages: 295918.00
CTRM income_statement (quarterly, 2024-12-31) — Salaries And Wages: 31500.00
CTRM cash_flow (annual, 2024-12-31) — Sale Of Business: 248715.00
CTRM cash_flow (annual, 2024-12-31) — Sale Of Investment: 52940067.00
CTRM cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 6851489.00
CTRM cash_flow (annual, 2024-12-31) — Sale Of PPE: 107867155.00
CTRM cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 5780.00
CTRM income_statement (annual, 2024-12-31) — Selling General And Administration: 6326343.00
CTRM income_statement (quarterly, 2024-12-31) — Selling General And Administration: 1436353.00
CTRM balance_sheet (annual, 2024-12-31) — Share Issued: 9662354.00
CTRM balance_sheet (quarterly, 2024-12-31) — Share Issued: 9662354.00
CTRM income_statement (annual, 2024-12-31) — Special Income Charges: 10227874.00
CTRM income_statement (quarterly, 2024-12-31) — Special Income Charges: -10476095.00
CTRM cash_flow (annual, 2024-12-31) — Stock Based Compensation: 9494.00
CTRM balance_sheet (annual, 2024-12-31) — Stockholders Equity: 570125236.00
CTRM balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 570125236.00
CTRM balance_sheet (annual, 2024-12-31) — Tangible Book Value: 455161120.00
CTRM balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 455161120.00
CTRM income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 27550.58
CTRM income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: -4515096.00
CTRM income_statement (annual, 2024-12-31) — Tax Provision: 133988.00
CTRM income_statement (quarterly, 2024-12-31) — Tax Provision: 34301.00
CTRM income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.01
CTRM income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.13
CTRM balance_sheet (annual, 2024-12-31) — Taxes Receivable: 11844503.00
CTRM balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 11844503.00
CTRM balance_sheet (annual, 2024-12-31) — Total Assets: 797376921.00
CTRM balance_sheet (quarterly, 2024-12-31) — Total Assets: 797376921.00
CTRM balance_sheet (annual, 2024-12-31) — Total Capitalization: 662650298.00
CTRM balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 662650298.00
CTRM balance_sheet (annual, 2024-12-31) — Total Debt: 111319821.00
CTRM balance_sheet (quarterly, 2024-12-31) — Total Debt: 111319821.00
CTRM balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 625465722.00
CTRM balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 625465722.00
CTRM income_statement (annual, 2024-12-31) — Total Expenses: 57731879.00
CTRM income_statement (quarterly, 2024-12-31) — Total Expenses: 15386163.00
CTRM balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 171911199.00
CTRM balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 171911199.00
CTRM balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 543518697.00
CTRM balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 543518697.00
CTRM balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 107509414.00
CTRM balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 107509414.00
CTRM income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 21426610.00
CTRM income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: -7011456.00
CTRM income_statement (annual, 2024-12-31) — Total Other Finance Cost: 2037110.00
CTRM income_statement (quarterly, 2024-12-31) — Total Other Finance Cost: 656129.00
CTRM balance_sheet (annual, 2024-12-31) — Total Tax Payable: 6642888.00
CTRM balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 6642888.00
CTRM income_statement (annual, 2024-12-31) — Total Unusual Items: 3443822.00
CTRM income_statement (quarterly, 2024-12-31) — Total Unusual Items: -36120768.00
CTRM income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 3443822.00
CTRM income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -36120768.00
CTRM cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 14664266.00
CTRM cash_flow (quarterly, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 24092116.00
CTRM balance_sheet (annual, 2024-12-31) — Working Capital: 189456439.00
CTRM balance_sheet (quarterly, 2024-12-31) — Working Capital: 189456439.00
CTRM income_statement (quarterly, 2025-03-31) — +Operating Expense: 5417232.00
CTRM income_statement (quarterly, 2025-03-31) — +Total Revenue: 20344159.00
CTRM balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 265341318.00
CTRM balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 65444538.00
CTRM income_statement (quarterly, 2025-03-31) — Basic Average Shares: 9662354.00
CTRM income_statement (quarterly, 2025-03-31) — Basic EPS: -2.18
CTRM cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 88616996.00
CTRM cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -218938.00
CTRM balance_sheet (quarterly, 2025-03-31) — Capital Stock: 78430469.00
CTRM balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 78344850.00
CTRM balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 136675066.00
CTRM cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -847222.00
CTRM cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -49907627.00
CTRM cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 40882968.00
CTRM cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -1735287.00
CTRM cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 2064552.00
CTRM cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -6589824.00
CTRM cash_flow (quarterly, 2025-03-31) — Change In Inventory: 818493.00
CTRM cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -2143434.00
CTRM cash_flow (quarterly, 2025-03-31) — Change In Payable: 2064552.00
CTRM cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -4525272.00
CTRM cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -1271340.00
CTRM cash_flow (quarterly, 2025-03-31) — Change In Receivables: -1955462.00
CTRM cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -9077015.00
CTRM cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -1955462.00
CTRM cash_flow (quarterly, 2025-03-31) — Changes In Cash: -10759946.00
CTRM balance_sheet (quarterly, 2025-03-31) — Common Stock: 9662.00
CTRM balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 478306436.00
CTRM income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 14957770.00
CTRM balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 16824163.00
CTRM balance_sheet (quarterly, 2025-03-31) — Current Assets: 234309262.00
CTRM balance_sheet (quarterly, 2025-03-31) — Current Debt: 50995096.00
CTRM balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 50995096.00
CTRM balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 101057040.00
CTRM cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 0.00
CTRM cash_flow (quarterly, 2025-03-31) — Deferred Tax: 0.00
CTRM cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 3449413.00
CTRM cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 3449413.00
CTRM income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 9662354.00
CTRM income_statement (quarterly, 2025-03-31) — Diluted EPS: -2.18
CTRM income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -21048320.00
CTRM cash_flow (quarterly, 2025-03-31) — Dividend Received Cfo: 5143521.00
CTRM balance_sheet (quarterly, 2025-03-31) — Duefrom Related Parties Current: 8022823.00
CTRM balance_sheet (quarterly, 2025-03-31) — Duefrom Related Parties Non Current: 2893839.00
CTRM balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 1108639.00
CTRM income_statement (quarterly, 2025-03-31) — EBIT: -30843.00
CTRM income_statement (quarterly, 2025-03-31) — EBITDA: 3418570.00
CTRM income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: -25797573.00
CTRM cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 25797573.00
CTRM cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 1289919.00
CTRM cash_flow (quarterly, 2025-03-31) — End Cash Position: 79146969.00
CTRM cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -49907627.00
CTRM cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -1954225.00
CTRM cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -7124205.00
CTRM cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 7639066.00
CTRM income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: -7619810.00
CTRM income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 5143521.00
CTRM balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 5476623.00
CTRM income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 4133036.00
CTRM balance_sheet (quarterly, 2025-03-31) — Goodwill: 22006417.00
CTRM balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 41604518.00
CTRM balance_sheet (quarterly, 2025-03-31) — Gross PPE: 162922583.00
CTRM income_statement (quarterly, 2025-03-31) — Gross Profit: 5386389.00
CTRM balance_sheet (quarterly, 2025-03-31) — Invested Capital: 533349490.00
CTRM cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 40882968.00
CTRM balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 268632879.00
CTRM balance_sheet (quarterly, 2025-03-31) — Investments In Other Ventures Under Equity Method: 268632879.00
CTRM cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 1577002.00
CTRM balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 4047958.00
CTRM balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 4047958.00
CTRM cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 1577002.00
CTRM cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -50527407.00
CTRM balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 268632879.00
CTRM balance_sheet (quarterly, 2025-03-31) — Minority Interest: 53912406.00
CTRM income_statement (quarterly, 2025-03-31) — Minority Interests: 4261079.00
CTRM cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -2595745.00
CTRM cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -3269185.00
CTRM income_statement (quarterly, 2025-03-31) — Net Income: -19085783.00
CTRM income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -21048320.00
CTRM income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -23346862.00
CTRM income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -19085783.00
CTRM income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -19085783.00
CTRM cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -23346862.00
CTRM income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -23346862.00
CTRM income_statement (quarterly, 2025-03-31) — Net Interest Income: -1287414.00
CTRM cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 13056330.00
CTRM cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -48950405.00
CTRM cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -48950405.00
CTRM income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -1287414.00
CTRM cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -110000.00
CTRM balance_sheet (quarterly, 2025-03-31) — Net PPE: 162922583.00
CTRM cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 30422383.00
CTRM balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 515122725.00
CTRM balance_sheet (quarterly, 2025-03-31) — Non Current Accounts Receivable: 2893839.00
CTRM balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 10520096.00
CTRM balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 10520096.00
CTRM income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 5894859.00
CTRM income_statement (quarterly, 2025-03-31) — Normalized Income: -16919030.13
CTRM cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -1735287.00
CTRM cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 23023993.00
CTRM income_statement (quarterly, 2025-03-31) — Operating Income: -30843.00
CTRM income_statement (quarterly, 2025-03-31) — Operating Revenue: 20344159.00
CTRM balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 9662354.00
CTRM balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 24166835.00
CTRM balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 50995096.00
CTRM balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 32129142.00
CTRM balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 5476623.00
CTRM income_statement (quarterly, 2025-03-31) — Other Gand A: 4133036.00
CTRM income_statement (quarterly, 2025-03-31) — Other Income Expense: -21734196.00
CTRM balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 19598101.00
CTRM cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -695724.00
CTRM balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 22615984.00
CTRM balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 6714322.00
CTRM income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 6539666.00
CTRM income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 1279215.00
CTRM balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 58330216.00
CTRM balance_sheet (quarterly, 2025-03-31) — Payables: 1108639.00
CTRM balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 17932802.00
CTRM balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 78420807.00
CTRM cash_flow (quarterly, 2025-03-31) — Preferred Stock Dividend Paid: -847222.00
CTRM income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 1962537.00
CTRM balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 78420807.00
CTRM income_statement (quarterly, 2025-03-31) — Pretax Income: -23052453.00
CTRM income_statement (quarterly, 2025-03-31) — Provision For Doubtful Accounts: 4981.00
CTRM cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 4981.00
CTRM cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -2595745.00
CTRM cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -8880477.00
CTRM cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -218938.00
CTRM balance_sheet (quarterly, 2025-03-31) — Receivables: 8022823.00
CTRM income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 14957770.00
CTRM income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 3449413.00
CTRM cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -50527407.00
CTRM balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 207478833.00
CTRM cash_flow (quarterly, 2025-03-31) — Sale Of Business: 0.00
CTRM cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 21936807.00
CTRM cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 30641321.00
CTRM income_statement (quarterly, 2025-03-31) — Selling General And Administration: 4133036.00
CTRM balance_sheet (quarterly, 2025-03-31) — Share Issued: 9662354.00
CTRM income_statement (quarterly, 2025-03-31) — Special Income Charges: -7619810.00
CTRM cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 53753.00
CTRM balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 556727243.00
CTRM balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 436701918.00
CTRM income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -309536.13
CTRM income_statement (quarterly, 2025-03-31) — Tax Provision: 294409.00
CTRM income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.13
CTRM balance_sheet (quarterly, 2025-03-31) — Total Assets: 732979065.00
CTRM balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 560775201.00
CTRM balance_sheet (quarterly, 2025-03-31) — Total Debt: 55043054.00
CTRM balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 610639649.00
CTRM income_statement (quarterly, 2025-03-31) — Total Expenses: 20375002.00
CTRM balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 122339416.00
CTRM balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 498669803.00
CTRM balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 21282376.00
CTRM income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -33448226.00
CTRM income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 1287414.00
CTRM income_statement (quarterly, 2025-03-31) — Total Unusual Items: -2476289.00
CTRM income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -2476289.00
CTRM cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: -291347.00
CTRM balance_sheet (quarterly, 2025-03-31) — Working Capital: 133252222.00
CTRM income_statement (quarterly, 2025-06-30) — Basic Average Shares: 9662354.00
CTRM income_statement (quarterly, 2025-06-30) — Basic EPS: 0.34
CTRM income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 54503652.00
CTRM income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.10
CTRM income_statement (quarterly, 2025-06-30) — EBIT: 7543259.00
CTRM income_statement (quarterly, 2025-06-30) — EBITDA: 10747001.00
CTRM income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 5467066.00
CTRM income_statement (quarterly, 2025-06-30) — Interest Expense: 897260.00
CTRM income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 897260.00
CTRM income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 4806449.00
CTRM income_statement (quarterly, 2025-06-30) — Normalized Income: -397233.71
CTRM income_statement (quarterly, 2025-06-30) — Other Gand A: 5414699.00
CTRM income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 2892749.00
CTRM cash_flow (quarterly, 2025-06-30) — Sale Of Business: 4137792.00
CTRM income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 275060.29
CTRM income_statement (quarterly, 2025-06-30) — Total Unusual Items: 5940552.00
CTRM income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 5940552.00
CTRM income_statement (quarterly, 2025-09-30) — +Operating Expense: 5451690.00
CTRM income_statement (quarterly, 2025-09-30) — +Total Revenue: 20963201.00
CTRM balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 265341318.00
CTRM balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 35689522.00
CTRM balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 50002128.00
CTRM income_statement (quarterly, 2025-09-30) — Basic Average Shares: 9662354.00
CTRM income_statement (quarterly, 2025-09-30) — Basic EPS: 1.76
CTRM cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 45909658.00
CTRM cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -343530.00
CTRM balance_sheet (quarterly, 2025-09-30) — Capital Stock: 139924487.00
CTRM balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 123830828.00
CTRM balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 181118282.00
CTRM cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -1250000.00
CTRM cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 71968319.00
CTRM cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 5381984.00
CTRM cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 1558600.00
CTRM cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -153609.00
CTRM cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -47539.00
CTRM cash_flow (quarterly, 2025-09-30) — Change In Inventory: 116559.00
CTRM cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -9318685.00
CTRM cash_flow (quarterly, 2025-09-30) — Change In Payable: -153609.00
CTRM cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -201148.00
CTRM cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -270387.00
CTRM cash_flow (quarterly, 2025-09-30) — Change In Receivables: -335706.00
CTRM cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -10009367.00
CTRM cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -335706.00
CTRM cash_flow (quarterly, 2025-09-30) — Changes In Cash: 78908903.00
CTRM balance_sheet (quarterly, 2025-09-30) — Common Stock: 9662.00
CTRM balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 513066770.00
CTRM income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 14210057.00
CTRM balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 16533143.00
CTRM balance_sheet (quarterly, 2025-09-30) — Current Assets: 258255563.00
CTRM balance_sheet (quarterly, 2025-09-30) — Current Debt: 1172540.00
CTRM balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1172540.00
CTRM balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 46069901.00
CTRM cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 3366070.00
CTRM cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 3366070.00
CTRM income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 84318733.00
CTRM income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.23
CTRM income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 17024109.00
CTRM cash_flow (quarterly, 2025-09-30) — Dividend Received Cfo: 8550649.00
CTRM balance_sheet (quarterly, 2025-09-30) — Duefrom Related Parties Current: 16200824.00
CTRM balance_sheet (quarterly, 2025-09-30) — Duefrom Related Parties Non Current: 2893839.00
CTRM balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 1062113.00
CTRM income_statement (quarterly, 2025-09-30) — EBIT: 20911270.00
CTRM income_statement (quarterly, 2025-09-30) — EBITDA: 24277340.00
CTRM income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: 2975904.00
CTRM cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: -3086875.00
CTRM cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 26026.00
CTRM cash_flow (quarterly, 2025-09-30) — End Cash Position: 124844587.00
CTRM cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 71968319.00
CTRM cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 1215070.00
CTRM cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -129651.00
CTRM cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 3674.00
CTRM income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: -4079.00
CTRM income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 3737518.00
CTRM balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 19947129.00
CTRM income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 4579321.00
CTRM balance_sheet (quarterly, 2025-09-30) — Goodwill: 23833120.00
CTRM balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 43989004.00
CTRM balance_sheet (quarterly, 2025-09-30) — Gross PPE: 158832352.00
CTRM income_statement (quarterly, 2025-09-30) — Gross Profit: 6753144.00
CTRM income_statement (quarterly, 2025-09-30) — Interest Expense: 372607.00
CTRM income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 372607.00
CTRM balance_sheet (quarterly, 2025-09-30) — Invested Capital: 518050065.00
CTRM cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 5381984.00
CTRM balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 50002128.00
CTRM balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 297135105.00
CTRM balance_sheet (quarterly, 2025-09-30) — Investments In Other Ventures Under Equity Method: 247132977.00
CTRM cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
CTRM balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 3810755.00
CTRM balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 3810755.00
CTRM cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
CTRM cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -560555.00
CTRM balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 247132977.00
CTRM balance_sheet (quarterly, 2025-09-30) — Minority Interest: 59068099.00
CTRM income_statement (quarterly, 2025-09-30) — Minority Interests: -1994323.00
CTRM cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -1129484.00
CTRM cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -1113923.00
CTRM income_statement (quarterly, 2025-09-30) — Net Income: 19001560.00
CTRM income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 17024109.00
CTRM income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 20995883.00
CTRM income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 19001560.00
CTRM income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 19001560.00
CTRM cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 20995883.00
CTRM income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 20995883.00
CTRM income_statement (quarterly, 2025-09-30) — Net Interest Income: -372607.00
CTRM cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 6449592.00
CTRM cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -560555.00
CTRM cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -560555.00
CTRM income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -372607.00
CTRM cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 13778874.00
CTRM cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 409080.00
CTRM balance_sheet (quarterly, 2025-09-30) — Net PPE: 158832352.00
CTRM cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -347204.00
CTRM balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 608992591.00
CTRM balance_sheet (quarterly, 2025-09-30) — Non Current Accounts Receivable: 2893839.00
CTRM balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 11423136.00
CTRM balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 11423136.00
CTRM income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 20543901.00
CTRM income_statement (quarterly, 2025-09-30) — Normalized Income: 15734800.88
CTRM cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 1558600.00
CTRM cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -4215399.00
CTRM income_statement (quarterly, 2025-09-30) — Operating Income: 1301454.00
CTRM income_statement (quarterly, 2025-09-30) — Operating Revenue: 20963201.00
CTRM balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 9662354.00
CTRM balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 25246935.00
CTRM balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 1172540.00
CTRM balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 27302105.00
CTRM balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 19947129.00
CTRM income_statement (quarterly, 2025-09-30) — Other Gand A: 4579321.00
CTRM income_statement (quarterly, 2025-09-30) — Other Income Expense: 19609816.00
CTRM balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 20155884.00
CTRM cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -2207527.00
CTRM balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 31341242.00
CTRM balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 19093619.00
CTRM income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 12900473.00
CTRM income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 866432.00
CTRM balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 57287454.00
CTRM balance_sheet (quarterly, 2025-09-30) — Payables: 1062113.00
CTRM balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 17595256.00
CTRM balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 139914825.00
CTRM cash_flow (quarterly, 2025-09-30) — Preferred Stock Dividend Paid: -1250000.00
CTRM income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 1977451.00
CTRM balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 139914825.00
CTRM income_statement (quarterly, 2025-09-30) — Pretax Income: 20538663.00
CTRM cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
CTRM income_statement (quarterly, 2025-09-30) — Provision For Doubtful Accounts: 5937.00
CTRM cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 5937.00
CTRM cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -2060841.00
CTRM cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -3179346.00
CTRM cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -343530.00
CTRM balance_sheet (quarterly, 2025-09-30) — Receivables: 16200824.00
CTRM income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 14210057.00
CTRM income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 3366070.00
CTRM cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -560555.00
CTRM balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 227768661.00
CTRM cash_flow (quarterly, 2025-09-30) — Sale Of Business: 931357.00
CTRM cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 9628938.00
CTRM cash_flow (quarterly, 2025-09-30) — Sale Of PPE: -3674.00
CTRM income_statement (quarterly, 2025-09-30) — Selling General And Administration: 4579321.00
CTRM balance_sheet (quarterly, 2025-09-30) — Share Issued: 9662354.00
CTRM income_statement (quarterly, 2025-09-30) — Special Income Charges: -4079.00
CTRM cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 65804.00
CTRM balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 652981595.00
CTRM balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 469077766.00
CTRM income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 466679.88
CTRM income_statement (quarterly, 2025-09-30) — Tax Provision: -457220.00
CTRM income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.13
CTRM balance_sheet (quarterly, 2025-09-30) — Total Assets: 792447105.00
CTRM balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 656792350.00
CTRM balance_sheet (quarterly, 2025-09-30) — Total Debt: 4983295.00
CTRM balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 712049694.00
CTRM income_statement (quarterly, 2025-09-30) — Total Expenses: 19661747.00
CTRM balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 80397411.00
CTRM balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 534191542.00
CTRM balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 34327510.00
CTRM income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 4273279.00
CTRM income_statement (quarterly, 2025-09-30) — Total Unusual Items: 3733439.00
CTRM income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 3733439.00
CTRM cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -14152088.00
CTRM balance_sheet (quarterly, 2025-09-30) — Working Capital: 212185662.00
CTRM income_statement (annual, 2025-12-31) — +Operating Expense: 21811177.00
CTRM income_statement (quarterly, 2025-12-31) — +Operating Expense: 4507650.00
CTRM income_statement (annual, 2025-12-31) — +Total Revenue: 81814405.00
CTRM income_statement (quarterly, 2025-12-31) — +Total Revenue: 22565392.00
CTRM balance_sheet (annual, 2025-12-31) — Accounts Payable: 3714698.00
CTRM balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 3714698.00
CTRM balance_sheet (annual, 2025-12-31) — Accounts Receivable: 7909514.00
CTRM balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 7909514.00
CTRM balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -31154278.00
CTRM balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -31154278.00
CTRM balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 265339741.00
CTRM balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 265339741.00
CTRM balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
CTRM balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
CTRM balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 0.00
CTRM balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 0.00
CTRM balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 9932222.00
CTRM balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 9932222.00
CTRM income_statement (annual, 2025-12-31) — Average Dilution Earnings: 8312675.00
CTRM income_statement (annual, 2025-12-31) — Basic Average Shares: 9662354.00
CTRM income_statement (quarterly, 2025-12-31) — Basic Average Shares: 9662354.00
CTRM income_statement (annual, 2025-12-31) — Basic EPS: 1.13
CTRM income_statement (quarterly, 2025-12-31) — Basic EPS: 1.21
CTRM cash_flow (annual, 2025-12-31) — Beginning Cash Position: 88616998.00
CTRM cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 124844587.00
CTRM cash_flow (annual, 2025-12-31) — Capital Expenditure: -889260.00
CTRM cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -172998.00
CTRM balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 7417626.00
CTRM balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 7417626.00
CTRM balance_sheet (annual, 2025-12-31) — Capital Stock: 80723749.00
CTRM balance_sheet (quarterly, 2025-12-31) — Capital Stock: 80723749.00
CTRM balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 151775129.00
CTRM balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 151775129.00
CTRM balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 180089828.00
CTRM balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 180089828.00
CTRM cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -4910934.00
CTRM cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -1563712.00
CTRM cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -46316381.00
CTRM cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -13748637.00
CTRM cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 97066285.00
CTRM cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 29086223.00
CTRM cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 10046351.00
CTRM cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 12464037.00
CTRM cash_flow (annual, 2025-12-31) — Cash Flow From Discontinued Operation: 0.00
CTRM cash_flow (annual, 2025-12-31) — Change In Account Payable: 1081688.00
CTRM cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 1408262.00
CTRM cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -7861871.00
CTRM cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 786786.00
CTRM cash_flow (annual, 2025-12-31) — Change In Inventory: 868044.00
CTRM cash_flow (quarterly, 2025-12-31) — Change In Inventory: -32675.00
CTRM cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -13187455.00
CTRM cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 927994.00
CTRM cash_flow (annual, 2025-12-31) — Change In Payable: 1081688.00
CTRM cash_flow (quarterly, 2025-12-31) — Change In Payable: 1408262.00
CTRM cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -6780183.00
CTRM cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 2195048.00
CTRM cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 509950.00
CTRM cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 1089107.00
CTRM cash_flow (annual, 2025-12-31) — Change In Receivables: -2982439.00
CTRM cash_flow (quarterly, 2025-12-31) — Change In Receivables: -1425375.00
CTRM cash_flow (annual, 2025-12-31) — Change In Working Capital: -21572083.00
CTRM cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 2754099.00
CTRM cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -2982439.00
CTRM cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -1425375.00
CTRM cash_flow (annual, 2025-12-31) — Changes In Cash: 60796255.00
CTRM cash_flow (quarterly, 2025-12-31) — Changes In Cash: 27801623.00
CTRM balance_sheet (annual, 2025-12-31) — Common Stock: 9662.00
CTRM balance_sheet (quarterly, 2025-12-31) — Common Stock: 9662.00
CTRM balance_sheet (annual, 2025-12-31) — Common Stock Equity: 525430695.00
CTRM balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 525430695.00
CTRM income_statement (annual, 2025-12-31) — Cost Of Revenue: 60096111.00
CTRM income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 16706777.00
CTRM balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 16700000.00
CTRM balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 16700000.00
CTRM balance_sheet (annual, 2025-12-31) — Current Assets: 221414874.00
CTRM balance_sheet (quarterly, 2025-12-31) — Current Assets: 221414874.00
CTRM balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 1203769.00
CTRM balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 1203769.00
CTRM balance_sheet (annual, 2025-12-31) — Current Debt: 5637620.00
CTRM balance_sheet (quarterly, 2025-12-31) — Current Debt: 5637620.00
CTRM balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 6841389.00
CTRM balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 6841389.00
CTRM balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 827210.00
CTRM balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 827210.00
CTRM balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 827210.00
CTRM balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 827210.00
CTRM balance_sheet (annual, 2025-12-31) — Current Liabilities: 34406904.00
CTRM balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 34406904.00
CTRM cash_flow (annual, 2025-12-31) — Deferred Income Tax: -1009194.00
CTRM cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -169756.00
CTRM cash_flow (annual, 2025-12-31) — Deferred Tax: -1009194.00
CTRM cash_flow (quarterly, 2025-12-31) — Deferred Tax: -169756.00
CTRM cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 14760087.00
CTRM cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 4740862.00
CTRM cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 14760087.00
CTRM cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 4740862.00
CTRM income_statement (annual, 2025-12-31) — Diluted Average Shares: 53652910.00
CTRM income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 57606487.00
CTRM income_statement (annual, 2025-12-31) — Diluted EPS: 0.36
CTRM income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.24
CTRM income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 19238302.00
CTRM income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 19996794.00
CTRM cash_flow (annual, 2025-12-31) — Dividend Received Cfo: 17967315.00
CTRM cash_flow (quarterly, 2025-12-31) — Dividend Received Cfo: 3619210.00
CTRM balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Current: 13155509.00
CTRM balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Current: 13155509.00
CTRM balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Non Current: 2893839.00
CTRM balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Non Current: 2893839.00
CTRM balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 1106606.00
CTRM balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 1106606.00
CTRM income_statement (annual, 2025-12-31) — EBIT: 25449446.00
CTRM income_statement (quarterly, 2025-12-31) — EBIT: 18759956.00
CTRM income_statement (annual, 2025-12-31) — EBITDA: 40209533.00
CTRM income_statement (quarterly, 2025-12-31) — EBITDA: 23500818.00
CTRM income_statement (annual, 2025-12-31) — Earnings From Equity Interest: -11081458.00
CTRM income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 10315794.00
CTRM cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 10970488.00
CTRM cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: -10315793.00
CTRM cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 3361876.00
CTRM cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 128917.00
CTRM cash_flow (annual, 2025-12-31) — End Cash Position: 152775129.00
CTRM cash_flow (quarterly, 2025-12-31) — End Cash Position: 152775129.00
CTRM balance_sheet (annual, 2025-12-31) — Financial Assets: 710802.00
CTRM balance_sheet (quarterly, 2025-12-31) — Financial Assets: 710802.00
CTRM cash_flow (annual, 2025-12-31) — Financing Cash Flow: -46316381.00
CTRM cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -13748637.00
CTRM cash_flow (annual, 2025-12-31) — Free Cash Flow: 9157091.00
CTRM cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 12291039.00
CTRM cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -10139355.00
CTRM cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -1428307.00
CTRM cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 7560097.00
CTRM cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 0.00
CTRM income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: -7250417.00
CTRM income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: -100014.00
CTRM income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 39199284.00
CTRM income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 24851179.00
CTRM balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 20628512.00